Introduction {#s2}
============

Acute pancreatitis (AP) is the leading gastrointestinal cause of hospital admissions, accounting for more than 275,000 admissions per year in the USA \[[@R01], [@R02]\]. Up to 75% of patients that present with AP to the emergency department require admission, which leads to an annual healthcare expenditure estimated at \$2.5 billion dollars \[[@R01]-[@R03]\]. Furthermore, nearly half of all readmissions are related to pancreatitis \[[@R04]\]. In the USA, alcohol and biliary disease are the most common causes of AP. With alcohol consumption in the USA on the decline in recent years, gallstone-related causes of pancreatitis are increasing, presumably due to a rise in obesity rates and an aging population \[[@R05], [@R06]\].

Nearly 0.6% of all hospitalizations result in discharge against medical advice (AMA) \[[@R07]-[@R10]\]. Historically, patients with low socioeconomic status (SES), a history of substance abuse, and mental illness have been found to have the highest rates of AMA discharges \[[@R07], [@R10]-[@R15]\]. The incidence and predictors of AMA discharge have been previously studied in patients with human immunodeficiency virus (HIV) infection, asthma, acute myocardial infarction, and inflammatory bowel disease (IBD), however this topic is yet to be studied in patients with pancreatitis. Patients with pancreatitis often have a wide variety of symptoms that are difficult to manage, which may lead to patient dissatisfaction. Leaving AMA results in incomplete treatment, increased rate of readmission, and increased health care utilization \[[@R07], [@R14]\]. Our study aims to determine the prevalence and trends of discharge AMA in patients with pancreatitis. Additionally, we sought to assess the predictors associated with discharge AMA.

Materials and Methods {#s3}
=====================

Data source {#s3a}
-----------

The Nationwide Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) was used to derive patient-relevant information between January 1, 2003 and December 31, 2016. The NIS is the largest publicly available all-payer claims-based database that contains clinical and resource utilization information on patient discharges from approximately 1,000 non-federal hospitals in 46 states. These data are stratified to represent approximately 20% of US inpatient hospitalizations across different hospital and geographic regions (random sample). National estimates of the entire US hospitalized population were calculated using the Agency for Healthcare Research and Quality (AHRQ) and weighting methods. The study was exempt by the institutional review board because the NIS is a publicly available and de-identified database.

Study sample {#s3b}
------------

Our study sample included patients aged 18 years or older who were hospitalized with a primary diagnosis of acute or chronic pancreatitis. We excluded patients with missing data on their discharge disposition, who were transferred out of the hospital, and those who died. Patients were identified using International Classification of Diseases-Ninth and Tenth Revision-Clinical Modification (ICD-9-CM and ICD-10-CM) codes ([Supplementary Material 1](#S1){ref-type="supplementary-material"}, [www.gastrores.org](http://www.gastrores.org)). The final sample included 7,158,894 pancreatitis hospitalizations.

Study endpoints {#s3c}
---------------

The primary outcome was disposition at discharge, specifically, whether a patient left the hospital AMA or was routinely discharged. Covariates included age, sex, race (white, black, Hispanic), insurance status (Medicare, Medicaid, private, or uninsured), income, bed size, weekend admission, and hospital location (urban, rural). In-hospital complications studied were urinary tract infection (UTI), acute kidney injury (AKI), acute dialysis requirement, septic shock, respiratory failure, length of stay (LOS), and cost.

Statistical analysis {#s3d}
--------------------

Weighted national estimates were used in all statistical analyses. The Cochrane-Armitage test was used to assess the statistical significance of the temporal trend incidence of AMA discharge in patients admitted with pancreatitis. Patients were categorized into patients with pancreatitis who left AMA and those who were routinely discharged. Descriptive statistics were presented as frequencies with percentages for categorical variables. Mean, standard deviation, median, 25th and 75th percentiles were reported for continuous measures. Baseline characteristics were compared using Pearson Chi-squared test and Fisher's exact test for categorical variables and an independent-samples *t*-test for continuous variables. Univariate and multivariate logistic regression was performed to estimate odds ratios (ORs) with 95% confidence intervals (CIs) to determine significant predictors for discharge AMA. A type I error of \< 0.05 was considered statistically significant. To analyze monotonic trend data over time, the Mann-Kendall trend test was employed with significance level at \< 5%. All statistical analyses were performed with SPSS version 25 (IBM Corporation, Armonk, NY).

Results {#s4}
=======

Between 2003 and 2016, a total of 7,158,894 admissions for pancreatitis were identified in the NIS. Of those, 199,351 (2.8%) left AMA. The incidence of discharge AMA has increased over time from 2.3% in 2003 to 3.2% in 2016 (P \< 0.001) ([Fig. 1](#F1){ref-type="fig"}). Patients who left AMA were more likely to be younger (49.4% vs. 5.8%, P \< 0.001), male (68.2% vs. 50.2%, P \< 0.001), black (24.4% vs. 17.5%, P \< 0.001), and of a lower SES (38.6% vs. 14.7%, P \< 0.001) compared to those who were routinely discharged ([Table 1](#T1){ref-type="table"}). Patients who left AMA had a greater prevalence of depression (10.6% vs. 7.1%, P \< 0.001), cirrhosis (10.9% vs. 8.6%, P \< 0.001), smoking (44.4% vs. 22.6%, P \< 0.001), drug abuse (18.4% vs. 6.8%, P \< 0.001), and HIV infection (3.0% vs. 1.4%, P \< 0.001). These patients' etiology of pancreatitis was more likely to be a result of alcohol use (52.3% vs. 23.5%, P \< 0.001) rather than biliary (9.5% vs. 22.3%, P \< 0.001) or other non-alcoholic causes (16% vs. 26.6%, P \< 0.001) ([Table 2](#T2){ref-type="table"}). The trends in etiology of pancreatitis over the study time period is shown in [Figure 2](#F2){ref-type="fig"}.
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###### Baseline Characteristics of the Study Population

  Baseline characteristics                     AMA                          No AMA                    P value
  -------------------------------------------- ---------------------------- ------------------------- ----------
  Patient characteristics                                                                             
    Age range                                                                                         \< 0.001
      18 - 44                                  49.4%                        32.2%                     
      45 - 64                                  44.8%                        40.7%                     
      \> 65                                    5.8%                         27.1%                     
    Male                                       68.2%                        50.2%                     \< 0.001
    Income                                                                                            \< 0.001
      0 - 25th percentile                      38.6%                        32.2%                     
      26th - 50th percentile                   26.6%                        26.4%                     
      51th - 75th percentile                   20.1%                        23.0%                     
      76th - 100th percentile                  14.7%                        18.4%                     
    Race                                                                                              \< 0.001
      White                                    58.4%                        64.7%                     
      Black                                    24.4%                        17.5%                     
      Hispanic                                 11.9%                        12.2%                     
    Payer                                                                                             \< 0.001
      Medicare                                 21.2%                        36.0%                     
      Medicaid                                 32.6%                        18.3%                     
      Private insurance                        17.6%                        31.0%                     
      Self-pay/no charge/other                 28.6%                        14.7%                     
  Hospital characteristics                                                                            
    Weekend admission                          26.8%                        24.8%                     \< 0.001
    Bed-size                                                                                          \< 0.001
      Small                                    15.4%                        14.8%                     
      Medium                                   30.0%                        26.6%                     
      Large                                    54.6%                        58.6%                     
    Urban                                      75.3%                        72.8%                     \< 0.001
    Rural                                      24.7%                        27.2%                     \< 0.001
    LOS (median (25%, 75%))                    2 (1, 3)                     4 (3, 7)                  \< 0.001
    Cost (mean ± SD (\$ in dollars))           21,090 (34,274)              43,556 (88,764)           \< 0.001
    Cost (median (25%, 75%) (\$ in dollars))   13,329,578 (7,588, 23,354)   22,419 (12,205, 43,448)   \< 0.001

AMA: against medical advice; N: number; SD: standard deviation; LOS: length of stay.

###### Patient Comorbidities, Complications and Interventions

  Comorbidities, complications and interventions   AMA     No AMA   P value
  ------------------------------------------------ ------- -------- ----------
  Comorbidities                                                     
    Diabetes mellitus                              20.6%   26.3%    \< 0.001
    Hypertension                                   40.6%   48.4%    \< 0.001
    Dyslipidemia                                   13.7%   24.1%    \< 0.001
    Coronary artery disease                        6.8%    12.0%    \< 0.001
    Peripheral vascular disease                    2.1%    4.1%     \< 0.001
    Atrial fibrillation/flutter                    2.1%    6.2%     \< 0.001
    Inflammatory bowel disease                     1.0%    1.4%     \< 0.001
    Liver cirrhosis                                10.9%   8.6%     \< 0.001
    Chronic kidney disease                         5.7%    8.7%     \< 0.001
    Anemia                                         17.6%   21.8%    \< 0.001
    COPD                                           13.6%   14.6%    \< 0.001
    Smoking                                        44.4%   22.6%    \< 0.001
    Drug abuse                                     18.4%   6.8%     \< 0.001
    Depression/psychosis                           10.6%   7.1%     \< 0.001
    HIV infection                                  3.0%    1.4%     \< 0.001
    Alcohol                                        52.3%   23.5%    \< 0.001
    Biliary pancreatitis                           9.5%    22.3%    \< 0.001
    Other cause of pancreatitis                    16.0%   26.6%    \< 0.001
  Complications                                                     
    Acute kidney injury                            7.3%    12.0%    \< 0.001
    Respiratory failure                            1.8%    5.0%     \< 0.001
    Sepsis                                         0.5%    2.1%     \< 0.001
    Urinary tract infection                        0.4%    0.7%     \< 0.001
    Gastrointestinal bleeding                      4.1%    3.0%     \< 0.001
  Interventions                                                     
    ERCP                                           1.8%    9.7%     \< 0.001
    Endoscopy                                      4.9%    9.8%     \< 0.001
      EGD                                          4.7%    9.0%     \< 0.001
      Colonoscopy                                  0.8%    2.1%     \< 0.001
    Acute kidney injury requiring hemodialysis     1.4%    2.6%     \< 0.001
    Blood transfusion                              3.0%    6.0%     \< 0.001

AMA: against medical advice; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; EGD: esophagogastroduodenoscopy; ERCP: endoscopic retrograde cholangiopancreatography.
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However, in-hospital complications including AKI, AKI-requiring hemodialysis, respiratory failure, and septic shock, and those receiving interventions such as endoscopic retrograde cholangiopancreatography (ERCP) were less frequently seen in patients who left AMA ([Table 2](#T2){ref-type="table"}).

In a multivariate logistic regression analysis, pancreatitis patients with the following characteristics were more likely to leave AMA: age 18 - 44 (OR: 4.14, 95% CI: 4.04 - 4.24, P \< 0.001), age 45 - 64 (OR: 3.21, 95% CI: 3.14 - 3.29, P \< 0.001), male (OR: 1.58, 95% CI: 1.56 - 1.60, P \< 0.001), black (OR: 1.06, 95% CI: 1.05 - 1.07, P \< 0.05), and weekend admission (OR: 1.08, 95% CI: 1.07 - 1.09, P \< 0.001). Patients with alcoholic pancreatitis were more likely to leave AMA (OR: 1.81, 95% CI: 1.79 - 1.83, P \< 0.001), than those with admissions secondary to biliary pancreatitis (OR: 0.85, 95% CI: 0.84 - 0.87, P \< 0.001). Patients who had history of depression (OR: 1.05, 95% CI: 1.03 - 1.07, P \< 0.001), drug abuse (OR: 1.44, 95% CI: 1.42 - 1.46, P \< 0.001) and HIV infection (OR: 1.25, 95% CI: 1.21 - 1.29, P \< 0.001) were more likely to be discharged AMA ([Table 3](#T3){ref-type="table"}).

###### Multivariate Logistic Regression Analysis for Predictors of Discharge Against Medical Advice Among Patients Admitted With Pancreatitis

  Predictors for AMA discharge    OR      95% CI for OR   P value   
  ------------------------------- ------- --------------- --------- ----------
  Age range                                                         
    18 - 44                       4.138   4.037           4.243     \< 0.001
    45 - 64                       3.214   3.139           3.292     \< 0.001
    \> 65                         Ref     Ref             Ref       Ref
  Male                            1.582   1.564           1.599     \< 0.001
  Race                                                              
    White                         Ref     Ref             Ref       Ref
    Black                         1.059   1.045           1.072     0.043
    Hispanic                      0.929   0.914           0.945     0.001
  Urban                           1.22    1.206           1.235     0.001
  Rural                           Ref     Ref             Ref       Ref
  Payer                                                             
    Medicare                      Ref     Ref             Ref       Ref
    Medicaid                      1.159   1.142           1.177     \< 0.001
    Private insurance             0.5     0.491           0.508     \< 0.001
    Self-pay/no charge/other      1.074   1.057           1.092     \< 0.001
  Weekend admission               1.082   1.07            1.094     \< 0.001
  Income                                                            
    0 - 25th percentile           1.096   1.079           1.114     \< 0.001
    26th - 50th percentile        1.053   1.036           1.07      \< 0.001
    51th - 75th percentile        0.962   0.946           0.979     \< 0.001
    76th - 100th percentile       Ref     Ref             Ref       Ref
  Diabetes mellitus               0.915   0.903           0.927     \< 0.001
  Hypertension                    0.941   0.931           0.951     \< 0.001
  Dyslipidemia                    0.747   0.736           0.758     \< 0.001
  Coronary artery disease         1.054   1.033           1.076     \< 0.001
  Peripheral vascular disease     0.794   0.768           0.821     \< 0.001
  Atrial fibrillation/flutter     0.76    0.735           0.786     \< 0.001
  Inflammatory bowel disease      0.8     0.762           0.841     \< 0.001
  Liver cirrhosis                 0.912   0.897           0.927     \< 0.001
  Anemia                          0.792   0.782           0.803     \< 0.001
  COPD                            0.974   0.959           0.988     \< 0.001
  Smoking                         1.532   1.515           1.548     \< 0.001
  Drug abuse                      1.443   1.424           1.463     \< 0.001
  Depression/psychosis            1.048   1.031           1.065     \< 0.001
  HIV infection                   1.251   1.212           1.291     \< 0.001
  ERCP                            0.362   0.348           0.376     \< 0.001
  Etiology                                                          
    Alcohol                       1.806   1.785           1.827     \< 0.001
    Biliary pancreatitis          0.851   0.835           0.867     \< 0.001
    Other cause of pancreatitis   Ref     Ref             Ref       Ref

AMA: against medical advice; COPD: chronic obstructive pulmonary disease; HIV: human immunodeficiency virus; ERCP: endoscopic retrograde cholangiopancreatography; OR: odds ratio; CI: confidence interval; Ref: reference.

Discussion {#s5}
==========

This study describes the prevalence of discharge AMA among patients who were admitted with acute and chronic pancreatitis and evaluates associated predictors. Additionally, our study reports the trend of discharge AMA over time. To our knowledge, this is the first and largest nationwide analysis to study AMA trends in pancreatitis patients. The main findings of our study were: 1) The number of discharges AMA increased over time; 2) Nearly 1 in 36 pancreatitis admissions leave AMA; 3) The predictors of AMA are patients that are younger, male, black, lower socioeconomic status, and have a history of depression, alcohol use, drug use, and HIV infection.

The trend of discharge AMA among patients admitted for pancreatitis has increased from 2003 - 2016 ([Fig. 1](#F1){ref-type="fig"}). Despite improvements in the management of pancreatitis which has led to decreased mortality over time, our study shows that AMA rates have continued to increase \[[@R06]\]. This may be explained by patients' lack of insurance, higher financial burdens, poor education, and increased dependence on drugs and alcohol among this cohort.

We found a rate of AMA discharge to be 2.8%, which is a notable increase compared to that of all-cause admissions (1.2-1.4%) \[[@R10], [@R16]\]. Naturally, discharge AMA rates vary by admission diagnosis. AMA rates for general medicine services have been reported to be 0.6%, while other conditions studied include: IBD (1.3%), cirrhosis (2.8%), pneumonia (1.3%), and HIV infection (13%) \[[@R16]-[@R19]\]. Comparatively, patients with a diagnosis of drug use carry a discharge AMA rate of 17%, while those with alcohol use disorder were found to leave AMA at a rate of 14% \[[@R12], [@R20]\]. In patients with HIV infection, asthma, acute myocardial infarction, and IBD the predictors of AMA discharge include recent drug use, dissatisfaction with narcotic prescriptions, family obligations, male sex, and financial constraints in those with low socioeconomic status \[[@R07], [@R11], [@R21], [@R22]\].

In a multivariate analysis, our findings suggest that there are several patient and socioeconomic factors associated with discharge AMA in pancreatitis patients. These factors include: younger age, male sex, black, insured by Medicaid, and lower household income ([Table 3](#T3){ref-type="table"}). Pancreatitis patients between the ages of 18 - 44 were four times more likely to discharge AMA compared to elderly patients (\> 65 years). Males also had a greater than 1.5-fold increased likelihood to discharge AMA. Those suffering from substance abuse with alcohol, drugs, and tobacco were nearly 1.5 times more likely to discharge AMA. Similarly, we also found socioeconomic status to have a bearing on the rate of discharge AMA \[[@R10], [@R11], [@R13], [@R14], [@R17]\]. These factors have been previously described as predictors for higher AMA rates in other populations \[[@R07], [@R10]-[@R15]\]. Based on these studies, patients of various diagnoses self-discharge for similar reasons, lending to the generalizability of our results. Interestingly, the etiology of pancreatitis was also predictive of whether a patient would leave AMA, such as those with alcohol as an etiology being approximately 1.8 times more likely to discharge AMA, while those with a biliary etiology were nearly 1.2 times less likely.

Understanding the reasons for patients discharging AMA is critical due to these patients having potentially worse outcomes and higher rates of readmission \[[@R13]\]. Patients are believed to discharge themselves AMA for a variety of reasons including personal or financial obligations, patient sense of improvement, lack of improvement, dissatisfaction with care, expectation of a shorter stay, underlying addiction with desire to use, and lack of a primary care physician \[[@R23]-[@R26]\]. Interestingly, studies have reported high-risk populations such as those with HIV infection and intravenous drug user (IVDU) to be less likely to leave AMA if they are receiving methadone or have social support from family and friends \[[@R27]\].

The LOS and cost of hospitalization in the AMA population was half that of patients who did not leave AMA ([Table 1](#T1){ref-type="table"}). Further studies are needed to determine the burden of AMA discharge in patients with pancreatitis who may present for a later readmission and with a more severe and complicated course.

Our study is not without limitations. First, the NIS is derived from hospital claims data and subject to the shortcomings of other administrative data sets. Inconsistencies related to over- or under-coding are possible, but AHRQ quality control measures should minimize those possibilities. Also, the ICD-9 codes used in our study have been used and/or validated in several prior studies \[[@R28]-[@R30]\]. Second, we used the principle diagnosis of pancreatitis to identify our study cohort. Hence, our data may not reflect the incidence or outcomes of pancreatitis among patients, who were admitted for another reason and developed pancreatitis during the hospitalization or were diagnosed with pancreatitis after admission. Moreover, due to the nature of the NIS database, each record accounts for a single hospitalization and not for an individual, which may lead to within-patient correlation. Third, NIS does not allow us to capture more granular information regarding the timing and severity of pancreatitis. Our data do not allow us to determine the reasons for discharge AMA, for example, differentiating between discharges due to inadequate symptom control and treatment versus dissatisfaction for other reasons (i.e. providers, hospital characteristics, etc.). Despite these limitations, we believe this study offers important insights into factors that may help prevent discharge AMA and therefore improve overall outcomes in patients with pancreatitis.

Future studies are necessary to examine the reasons for discharge AMA among this patient population. Improvements in treatment and symptoms control as well as identification of patients at high risk for discharge AMA may help to reduce self-discharge, readmissions, hospital costs, and subsequent morbidity.
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